For: | Zhu ZS, Wang JM, Chen SL. Mesenteric artery remodeling and effects of imidapril and irbesartan on it in spontaneously hypertensive rats. World J Gastroenterol 2004; 10(10): 1471-1475 [PMID: 15133856 DOI: 10.3748/wjg.v10.i10.1471] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i10/1471.htm |
Number | Citing Articles |
1 |
Shivmuni Sarup, Alexander G. Obukhov, Shubhi Raizada, Rajat Atre, Mirza S. Baig. Drug repurposing in the treatment of chronic inflammatory diseases. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-024-00730-1
|
2 |
Márcio A. F. De Godoy, Satish Rattan. Angiotensin-Converting Enzyme and Angiotensin II Receptor Subtype 1 Inhibitors Restitute Hypertensive Internal Anal Sphincter in the Spontaneously Hypertensive Rats. Journal of Pharmacology and Experimental Therapeutics 2006; 318(2): 725 doi: 10.1124/jpet.106.103366
|
3 |
Rawikant Kamolphiwong, Kanyanatt Kanokwiroon, Weerinrada Wongrin, Parunya Chaiyawat, Jeerawan Klangjorhor, Jongkolnee Settakorn, Pimpisa Teeyakasem, Apiwat Sangphukieo, Dumnoensun Pruksakorn. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing. Gene 2023; 856: 147106 doi: 10.1016/j.gene.2022.147106
|
4 |
Tony E. Walshe, Vandana S. Dole, Arindel S.R. Maharaj, Ian S. Patten, Denisa D. Wagner, Patricia A. D'Amore. Inhibition of VEGF or TGF-β Signaling Activates Endothelium and Increases Leukocyte Rolling. Arteriosclerosis, Thrombosis, and Vascular Biology 2009; 29(8): 1185 doi: 10.1161/ATVBAHA.109.186742
|
5 |
M.R. Jones, K.A. Schrader, Y. Shen, E. Pleasance, C. Ch'ng, N. Dar, S. Yip, D.J. Renouf, J.E. Schein, A.J. Mungall, Y. Zhao, R. Moore, Y. Ma, B.S. Sheffield, T. Ng, S.J.M. Jones, M.A. Marra, J. Laskin, H.J. Lim. Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer. Annals of Oncology 2016; 27(5): 801 doi: 10.1093/annonc/mdw060
|
6 |
Ahmed M. Kabel, Abdulaziz A. Alzahrani, Nawaf M. Bawazir, Rayan O. Khawtani, Hany H. Arab. Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity. Journal of Infection and Chemotherapy 2018; 24(8): 623 doi: 10.1016/j.jiac.2018.03.010
|